Expansion in Biomarkers Arbor Assays continually releases new ELISA kits targeting crucial biomarkers such as Thromboxane B2, TNF-alpha, BNP, and SARS-CoV-2 antibodies, indicating a strong pipeline of innovative products that cater to diverse research needs in cardiology, infectious diseases, and immunology.

Focus on Disease Research Recent product launches for COVID-19 antibody testing and cardiac biomarkers suggest opportunities to engage with diagnostic labs, clinical research organizations, and healthcare providers seeking reliable assay solutions for disease detection and monitoring.

Small but Growing Market With an annual revenue estimate of up to $25 million and a dedicated team of 11-50 employees, Arbor Assays is positioned as a nimble player in the biotech research space, potentially seeking scalable distribution channels and strategic partnerships to accelerate growth.

Commitment to Quality As an employee-owned company emphasizing quality, integrity, and customer support, Arbor Assays values strong customer relationships and may benefit from sales approaches highlighting their commitment to scientific reliability and tailored solutions.

Technology and Innovation Utilizing a modern tech stack including Shopify and web analysis tools like Hotjar, Arbor Assays demonstrates a forward-looking digital presence, offering opportunities to enhance online outreach, e-commerce capabilities, and targeted marketing campaigns to reach research institutions globally.